Skip to main content

Advertisement

ADVERTISEMENT

Recovery

News
09/01/2023
About 1 in 5 patients in Washington state who used cannabis within the past year met the criteria for cannabis use disorder, according to a Kaiser Permanente Washington Health Research Institute study.
About 1 in 5 patients in Washington state who used cannabis within the past year met the criteria for cannabis use disorder, according to a Kaiser Permanente Washington Health Research Institute study.
About 1 in 5 patients in...
09/01/2023
Addiction Professional
News
08/29/2023
Overdoses involving the emerging subclass of synthetic opioids produced significantly more intense impacts than overdoses involving fentanyl, according to a study released on Tuesday.
Overdoses involving the emerging subclass of synthetic opioids produced significantly more intense impacts than overdoses involving fentanyl, according to a study released on Tuesday.
Overdoses involving the emerging...
08/29/2023
Addiction Professional
News
08/18/2023
Two-thirds of adults in the US say they or a family member have been addicted to alcohol or drugs, experienced homelessness due to addiction, or experienced an overdose that led to an emergency room visit, hospitalization, or death.
Two-thirds of adults in the US say they or a family member have been addicted to alcohol or drugs, experienced homelessness due to addiction, or experienced an overdose that led to an emergency room visit, hospitalization, or death.
Two-thirds of adults in the US...
08/18/2023
Addiction Professional
News
08/07/2023
A study released by NIDA, NIH, and CDC finds that 22% of US adults with opioid use disorder receive MAT, and certain demographic groups are disproportionately impacted.
A study released by NIDA, NIH, and CDC finds that 22% of US adults with opioid use disorder receive MAT, and certain demographic groups are disproportionately impacted.
A study released by NIDA, NIH,...
08/07/2023
Addiction Professional
John de Miranda, EdM, CRC
Perspectives
08/04/2023
Harm reduction strategies have been viewed with skepticism by many. The opioid epidemic has forced a re-evaluation of both harm reduction’s place in the treatment toolbox and the role of treatment professionals.
Harm reduction strategies have been viewed with skepticism by many. The opioid epidemic has forced a re-evaluation of both harm reduction’s place in the treatment toolbox and the role of treatment professionals.
Harm reduction strategies have...
08/04/2023
Addiction Professional
News
08/01/2023
Clinicians waivered under education-exempted HHS buprenorphine practice guidelines were less likely than traditionally waivered clinicians to prescribe buprenorphine and more likely to practice in emergency/urgent care settings, according to...
Clinicians waivered under education-exempted HHS buprenorphine practice guidelines were less likely than traditionally waivered clinicians to prescribe buprenorphine and more likely to practice in emergency/urgent care settings, according to...
Clinicians waivered under...
08/01/2023
Addiction Professional
News
07/28/2023
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol...
07/28/2023
Addiction Professional
News
07/18/2023
A new study released by the University of Central Florida finds that although most insurance plans cover the sublingual formulation of buprenorphine, significant barriers exist for the extended-release, injectable formulation.
A new study released by the University of Central Florida finds that although most insurance plans cover the sublingual formulation of buprenorphine, significant barriers exist for the extended-release, injectable formulation.
A new study released by the...
07/18/2023
Addiction Professional
News
07/05/2023
A drug designed to treat cannabis use disorder by selectively inhibiting the signaling pathway of the cannabinoid receptor has shown promise as a safe and effective treatment in a recent clinical trial.
A drug designed to treat cannabis use disorder by selectively inhibiting the signaling pathway of the cannabinoid receptor has shown promise as a safe and effective treatment in a recent clinical trial.
A drug designed to treat...
07/05/2023
Addiction Professional
News
06/20/2023
The discrepancy in overdose deaths between men and women identified in a NIDA-backed study could be attributed to a combination of biological, behavioral, and social factors.
The discrepancy in overdose deaths between men and women identified in a NIDA-backed study could be attributed to a combination of biological, behavioral, and social factors.
The discrepancy in overdose...
06/20/2023
Addiction Professional

Advertisement

Advertisement